This case highlights the importance of recognizing that anti-glutamate decarboxylase antibody positivity and corresponding hyperglycemia can be induced transiently by immunoglobulin therapy and do not necessarily indicate progression to type 1 diabetes mellitus. This evidence concerns the gene GLUL and type 1 diabetes mellitus.